Johnson & JohnsonPenjualan
$JNJ Looks a certain short from here. $120 NEXT STOP
*****INVESTORS IN JNJ CAN'T WAIT FOR MAY TO BE OVER, ALREADY DOWN 7% AND 5% IN ONE DAY , NEXT SUPPORT IS ANOTHER 6% AWAY AND IT LOOKS VERY MUCH LIKE THAT IS WHERE THE PRICE IS GOING. OPIOID LITIGATIONS CONTINUE TO BE A DRAG ON SENTIMENT AND THAT ISSUE WILL INTENSIFY AS THE CRISIS INTENSIFIES.
AVERAGE ANALYSTS RETAIL PRICE $148
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
P/E RATIO 24
JNJ CAN'T WAIT FOR MAY TO BE OVER, ALREADY DOWN 7% AND 5% IN ONE DAY , NEXT SUPPORT IS ANOTHER 6% AWAY AND IT LOOKS VERY MUCH LIKE THAT IS WHERE THE PRICE IS GOING. OPIOID LITIGATIONS CONTINUE TO BE A DRAG ON SENTIMENT AND THAT ISSUE WILL INTENSIFY AS THE CRISIS INTENSIFIES. AVERAGE ANALYSTS RETAIL PRICE $148
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
P/E RATIO 24
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.